Abstract
BackgroundThe criteria for antiphospholipid syndrome (APS) include severe preeclampsia and/or placental insufficiency leading to preterm delivery before 34 weeks of gestation, but this APS manifestation has been rarely studied. Thus, we report a series of severe preeclampsia occurred in patients with APS.MethodsWe retrospectively analysed data of women with APS (Sydney criteria) who experienced severe preeclampsia with delivery before 34 weeks’ gestation between 2000 and 2017 at five French internal medicine departments and one Italian rheumatology unit.ResultsThe 40 women had a mean age of 30.5 ± 4.6 years at their first episode of preeclampsia; 21 were nulligravid (52.5%), 12 (30%) had already been diagnosed with APS, and 21 (52.5%) had a triple-positive antiphospholipid (aPL) antibody test.Preeclampsia occurred at a median gestational age of 25.5 weeks (IQR 23-29). It was associated with HELLP in 18 cases (45%), eclampsia in 6 (15%), placental abruption in 3 (7.5%), catastrophic APS in 3 (7.5%), and foetal and neonatal death in 11 and 15 cases. Overall, 14 (35%) children survived, born at a median gestational age of 31 weeks.Among other APS criteria, 16 women (40%) experienced at least one thrombosis, 17 (42.5%) an intrauterine foetal death, and 19 (47.5%) at least one episode of HELLP during follow-up (median 5 years, IQR = 2-8). None had three or more consecutive miscarriages. Notably, 12 women (30%) had systemic lupus erythematosus.ConclusionsSevere preeclampsia led to high mortality in the offspring. Almost half of these women experienced other APS features, but not three consecutive miscarriages.
Highlights
The criteria for antiphospholipid syndrome (APS) include severe preeclampsia and/or placental insufficiency leading to preterm delivery before 34 weeks of gestation, but this APS manifestation has been rarely studied
The 2006 APS classification criteria [2] include three obstetric manifestations: (1) at least three unexplained and consecutive pregnancy losses before the 10th weeks of gestation, (2) an unexplained intrauterine foetal death (IUFD) ≥ 10th week, and (3) a preterm birth ≤ the 34th week because of severe preeclampsia or other recognised features of placental insufficiency. These obstetric criteria were established by expert consensus, little is known about preeclampsia in APS patients
We recently reported a series of 65 APS patients with foetal deaths [3] in which foetal death was often the inaugural sign of APS and frequently associated with other APS criteria, in particular, preeclampsia and thromboses, while the ‘3 consecutive early miscarriages’ criterion was met in only one patient [3]
Summary
The criteria for antiphospholipid syndrome (APS) include severe preeclampsia and/or placental insufficiency leading to preterm delivery before 34 weeks of gestation, but this APS manifestation has been rarely studied. The 2006 APS classification criteria [2] include three obstetric manifestations: (1) at least three unexplained and consecutive pregnancy losses before the 10th weeks of gestation, (2) an unexplained intrauterine foetal death (IUFD) ≥ 10th week, and (3) a preterm birth ≤ the 34th week because of severe preeclampsia or other recognised features of placental insufficiency. These obstetric criteria were established by expert consensus, little is known about preeclampsia in APS patients. This study did not, assess the other classification criteria
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
